Nordic Biologics Master Directory 2026

The Nordic region has emerged as one of Europe's most dynamic biologics ecosystems, with 400+ companies spanning therapeutic development, contract services, and enabling technologies. This directory profiles the complete landscape, from global giants like Novo Nordisk (market cap $309B) and AstraZeneca to clinical-stage innovators and specialised CDMOs.

The region's unique advantages include world-class research infrastructure, generous R&D incentives, single-payer healthcare systems enabling clinical trials, and unique population genetics databases.

Complete the Form to get Full Access the Webinar Video

First Name

Last Name

Professional E-mail

Job Title

Company Name

Phone Number

Country

You acknowledge and agree to IMAPAC's Term of Service and to use your contact information provided to communicate with about offerings by IMAPAC, its brands, affiliates and/or third-party partners consistent with IMAPAC's Privacy Policy.

Thank you! Click below to view/download:

Oops! Something went wrong while submitting the form.